| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.074 | 0.09 |